You are here: Industry Insights > Epilepsy

News List

SciSparc to Commence Pre-Clinical Study Using CBD-Based Treatment for Epilepsy americanpharmaceuticalreview
March 16, 2021
SciSparc has entered into an agreement with The Sheba Fund for Health Services and Research, to perform a pre-clinical study for the evaluation of the Company's SCI-210 drug development program, a proprietary novel pharmaceutical preparation ...
Alkem launches anti-epileptic drug BRIVASURE (Brivaracetam) expresspharma
March 16, 2021
Alkem Laboratories announced the launch of Brivasure, an affordable anti-epileptic drug for the treatment of epilepsy in India.
NATCO launches Brivaracetam tablets in India expresspharma
March 01, 2021
Natco Pharma announced the launch of Brivaracetam tablets under brand BRECITA in India.
Sun Pharma to launch entire range of Brivaracetam for epilepsy treatment in India expresspharma
February 24, 2021
Brivaracetam is an anti-epileptic drug (AEDs) with fast onset of action and promising efficacy.
Jazz Pharma to buy GW Pharma for $7.2 billion, adding cannabis-based drug to portfolio expresspharma
February 04, 2021
The deal will allow Jazz to move beyond sleep disorders and cancer treatments by beefing up its neuroscience unit.
MHRA review recommends discussion around epilepsy medication and pregnancy pharmatimes
January 11, 2021
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has urged women receiving epilepsy medication to discuss their treatment options if they may be pregnant or are planning to become pregnant in the future.
Cerebral Therapeutics announces enrolment of first patient in phase 2b trial in epilepsy pharmaceutical-business-review
November 20, 2020
Cerebral Therapeutics announced that the first patient has been enrolled in a Phase 2b study of intracerebroventricular drug delivery of the anti-seizure medication CT-010 in patients with medically refractory epilepsy.
Sihuan Pharmaceutical's Gabapentin Capsules was Granted Drug Production Approval, the Third Company Obtained Approval in China prnasia
October 22, 2020
Sihuan Pharmaceutical Holdings Group Ltd. is pleased to announce that the National Medical Products Administration has granted drug production approval for the Group's gabapentin capsules.
Cobra Biologics and CombiGene Partner contractpharma
September 24, 2020
Sign agreement to secure GMP production of plasmids for production of CG01 gene therapy.
SMC accepts 14 new medicines for use by NHS Scotland pharmatimes
September 17, 2020
Fourteen newly licensed medicines have been accepted for use on NHS Scotland by the Scottish Medicines Consortium (SMC), bringing a raft of new treatment options for conditions including epilepsy, depression and cancer.

Previous page 1 2 3 4 5 6 Next page